PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 103 filers reported holding PROMETHEUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,957,309 | +164.9% | 27,556 | +171.5% | 0.00% | – |
Q4 2022 | $1,116,390 | +211.8% | 10,149 | +67.2% | 0.00% | – |
Q3 2022 | $358,000 | +126.6% | 6,070 | +8.1% | 0.00% | – |
Q2 2022 | $158,000 | -19.8% | 5,613 | +7.4% | 0.00% | – |
Q1 2022 | $197,000 | -18.3% | 5,224 | -14.3% | 0.00% | – |
Q4 2021 | $241,000 | +947.8% | 6,097 | +541.1% | 0.00% | – |
Q3 2021 | $23,000 | +4.5% | 951 | +5.4% | 0.00% | – |
Q2 2021 | $22,000 | – | 902 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 1,848,024 | $203,282,640 | 93.46% |
CHI Advisors LLC | 923,800 | $101,618,000 | 27.06% |
Sio Capital Management, LLC | 574,200 | $63,162,000 | 23.36% |
Cormorant Asset Management, LP | 2,090,000 | $229,900 | 15.38% |
Boxer Capital, LLC | 1,897,500 | $208,725,000 | 11.00% |
SEVEN GRAND MANAGERS, LLC | 20,105 | $2,211,550 | 10.34% |
Decheng Capital Management III (Cayman), LLC | 250,000 | $27,500,000 | 10.29% |
Ikarian Capital, LLC | 288,926 | $31,781,860 | 7.67% |
RTW INVESTMENTS, LP | 3,354,303 | $368,973,330 | 7.53% |
Waypoint Capital Advisors, LLC | 171,181 | $18,829,910 | 6.53% |